Ascendis Pharma (ASND)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q2 2026 | |||||
| ≡ | Polen Capital Management | Sell 100.00% | 1,812 | 0.00 | |
| Q4 2025 | |||||
| ≡ | Polen Capital Management | Reduce 56.22% | 1,555 | 0.00 | |
| Q4 2021 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Sell 100.00% | 1,436,981 | 0.77 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.